Vijaya Diagnostic Centre's Q2 FY 2025-26 Quarterly Results

Result Summary

• Vijaya Diagnostic Centre Ltd reported a 6.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 10.9%.
• Its expenses for the quarter were up by 4.8% QoQ and 15.0% YoY.
• The net profit increased 12.2% QoQ and increased 2.7% YoY.
• The earnings per share (EPS) of Vijaya Diagnostic Centre Ltd stood at 4.2 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Vijaya Diagnostic Centre Ltd is a leading provider of diagnostic and related healthcare tests in India. The company offers a comprehensive range of diagnostic services, including pathology and radiology, through its network of diagnostic centers. The company primarily operates in the healthcare sector, focusing on diagnostic services, which are essential for the early detection, diagnosis, and monitoring of diseases. As of the latest data, no recent major developments specifically affecting Vijaya Diagnostic Centre Ltd have been noted. The company is known for its emphasis on high-quality, accurate diagnostic services, catering to a broad spectrum of healthcare needs across various regions.

Revenue

In the second quarter of fiscal year 2026 (Q2FY26), Vijaya Diagnostic Centre Ltd reported a total income of ₹207.81 crores. This marked a quarter-over-quarter (QoQ) increase of 6.5% compared to ₹195.10 crores in Q1FY26 and a year-over-year (YoY) increase of 10.9% from ₹187.46 crores in Q2FY25. The growth in total income demonstrates a positive trend in the company's revenue generation capabilities over both the previous quarter and the same quarter of the previous year. These figures reflect the company's ability to enhance its revenue streams, potentially driven by an increase in service uptake, expansion of service offerings, or improved operational efficiencies.

Profitability

The company's profitability metrics indicate a stable performance with slight improvements. The profit before tax (PBT) for Q2FY26 was ₹57.98 crores, showing an 11.1% increase QoQ from ₹52.21 crores in Q1FY26 and a 1.4% increase YoY from ₹57.19 crores in Q2FY25. This increase in PBT suggests the company's ability to manage expenses while increasing revenue. After accounting for taxes of ₹14.70 crores, which rose 7.9% QoQ but decreased 2.4% YoY, the profit after tax (PAT) stood at ₹43.28 crores. This represents a 12.2% QoQ increase from ₹38.59 crores and a 2.7% YoY increase from ₹42.13 crores. The earnings per share (EPS) for Q2FY26 was ₹4.20, compared to ₹3.75 in Q1FY26 and ₹4.08 in Q2FY25, reflecting similar patterns of growth.

Operating Metrics

The total expenses for Vijaya Diagnostic Centre Ltd in Q2FY26 amounted to ₹149.83 crores, marking a 4.8% QoQ increase from ₹142.90 crores in Q1FY26 and a 15.0% YoY rise from ₹130.28 crores in Q2FY25. This rise in expenses may be attributed to increased operational costs, expansion activities, or inflationary pressures. Despite the rise in expenses, the company managed to maintain a strong profit margin, as indicated by the increase in both PBT and PAT. The company's ability to manage its cost structure effectively while growing its revenue base is evident from the data provided. Key financial ratios such as the P/E ratio, debt-to-equity ratio, and current ratio could not be calculated as the necessary data was not provided.